243 related articles for article (PubMed ID: 11126380)
21. Cholangiocarcinoma: principles and current trends.
Zografos GN; Farfaras A; Zagouri F; Chrysikos D; Karaliotas K
Hepatobiliary Pancreat Dis Int; 2011 Feb; 10(1):10-20. PubMed ID: 21269929
[TBL] [Abstract][Full Text] [Related]
22. Left hemihepatectomy and caudate lobectomy and complete extrahepatic bile duct resection using transduodenal approach for hilar cholangiocarcinoma arsing from biliary papillomatosis.
Kim JK; Hwang HK; Park JS; Cho SI; Yoon DS; Chi HS
J Surg Oncol; 2008 Aug; 98(2):139-42. PubMed ID: 18521837
[TBL] [Abstract][Full Text] [Related]
23. Follicular lymphoma of the extrahepatic bile duct mimicking cholangiocarcinoma.
Sugawara G; Nagino M; Oda K; Nishio H; Ebata T; Nimura Y
J Hepatobiliary Pancreat Surg; 2008; 15(2):196-9. PubMed ID: 18392714
[TBL] [Abstract][Full Text] [Related]
24. Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinoma.
Tzovaras V; Liberopoulos EN; Zioga A; Pavlidis N; Elisaf M
Oncology; 2007; 73(1-2):127-9. PubMed ID: 18337625
[TBL] [Abstract][Full Text] [Related]
25. Biliary ascariasis and extrahepatic cholangiocarcinoma.
Toufeeq Khan TF; Muniandy S
Singapore Med J; 1995 Oct; 36(5):570. PubMed ID: 8882553
[No Abstract] [Full Text] [Related]
26. Cross-sectional imaging of biliary tumors: current clinical status and future developments.
Zech CJ; Schoenberg SO; Reiser M; Helmberger T
Eur Radiol; 2004 Jul; 14(7):1174-87. PubMed ID: 15106016
[TBL] [Abstract][Full Text] [Related]
27. Cholangiocarcinoma: risk factors, diagnosis and management.
Acalovschi M
Rom J Intern Med; 2004; 42(1):41-58. PubMed ID: 15529594
[TBL] [Abstract][Full Text] [Related]
28. [An analysis on prognostic factors of hilar cholangiocarcinoma].
Zhou LX; Zhang ZW; Xu ZY
Zhonghua Yi Xue Za Zhi; 2009 May; 89(18):1275-7. PubMed ID: 19595185
[TBL] [Abstract][Full Text] [Related]
29. [Current diagnostics and therapy for carcinomas of the biliary tree and gallbladder].
Wiedmann M; Schoppmeyer K; Witzigmann H; Hauss J; Mössner J; Caca K
Z Gastroenterol; 2005 Mar; 43(3):305-15. PubMed ID: 15765304
[TBL] [Abstract][Full Text] [Related]
30. Role of magnetic resonance in characterising extrahepatic cholangiocarcinomas.
Guarise A; Venturini S; Faccioli N; Pinali L; Morana G
Radiol Med; 2006 Jun; 111(4):526-38. PubMed ID: 16779539
[TBL] [Abstract][Full Text] [Related]
31. Cholangiocarcinoma: clinical significance of tumor location along the extrahepatic bile duct.
Alden ME; Waterman FM; Topham AK; Barbot DJ; Shapiro MJ; Mohiuddin M
Radiology; 1995 Nov; 197(2):511-6. PubMed ID: 7480704
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and management of cholangiocarcinoma in primary sclerosing cholangitis.
Ahrendt SA; Pitt HA; Nakeeb A; Klein AS; Lillemoe KD; Kalloo AN; Cameron JL
J Gastrointest Surg; 1999; 3(4):357-67; discussion 367-8. PubMed ID: 10482687
[TBL] [Abstract][Full Text] [Related]
33. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.
Aljiffry M; Walsh MJ; Molinari M
World J Gastroenterol; 2009 Sep; 15(34):4240-62. PubMed ID: 19750567
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and surgical approaches in hilar cholangiocarcinoma.
Otto G
Int J Colorectal Dis; 2007 Feb; 22(2):101-8. PubMed ID: 16575606
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant photodynamic therapy for bile duct carcinoma after surgery: a preliminary study.
Nanashima A; Yamaguchi H; Shibasaki S; Ide N; Sawai T; Tsuji T; Hidaka S; Sumida Y; Nakagoe T; Nagayasu T
J Gastroenterol; 2004 Nov; 39(11):1095-101. PubMed ID: 15580404
[TBL] [Abstract][Full Text] [Related]
36. Single centre experience with surgical treatment of hilar cholangiocarcinoma.
Vladov N; Lukanova Ts; Takorov I; Mutafchiyski V; Vasilevski I; Sergeev S; Odisseeva E
Chirurgia (Bucur); 2013; 108(3):299-303. PubMed ID: 23790776
[TBL] [Abstract][Full Text] [Related]
37. Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience.
Blom D; Schwartz SI
Arch Surg; 2001 Feb; 136(2):209-15. PubMed ID: 11177143
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial.
Yang J; Wang J; Zhou H; Zhou Y; Wang Y; Jin H; Lou Q; Zhang X
Endoscopy; 2018 Aug; 50(8):751-760. PubMed ID: 29342492
[TBL] [Abstract][Full Text] [Related]
39. A modern approach to malignant hilar biliary obstruction.
Freeman ML; Sielaff TD
Rev Gastroenterol Disord; 2003; 3(4):187-201. PubMed ID: 14668691
[TBL] [Abstract][Full Text] [Related]
40. Significance of inflammatory and nutritional markers as prognostic predictors in patients with resected distal cholangiocarcinoma.
Kitasato A; Kuroki T
Asian J Surg; 2021 Dec; 44(12):1574-1576. PubMed ID: 34503876
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
